It is exciting when two laboratories independently verify each other's findings as a result of parallel research efforts. This apparently was the case as highlighted in Glover's comment (Glover, 1995) on our case report "An unusual reaction to opioid blockade with naltrexone in a case of posttraumatic stress disorder" (Ibarra, et al., 1994). However, several points made by Glover require clarification and/or correction.Glover seeks to make a point that the reactions reported in Ibarra et al. (1994) are not unusual. The Physician's Desk Reference (1995) indicates that some components of the reaction to naltrexone experienced by our subject have an expected incidence of less than 1%, e.g., increased blood pressure, visual disturbance. Other components of the reaction to naltrexone are not expected at all, e.g., rage, explosive behavior. By statistical criteria, cardiovascular reactions observed in response to naltrexone in our case study were beyond two and, in some cases, three standard deviations from the rest of our study subjects. Our cardiovascular results are ignored by Glover. In our opinion these results denote an unusual response. In fact, our cardiovascular results suggest that opioid-mediated phenomena in PTSD involve not only behavioral responses, but also may include the autonomic nervous system and, hence, a wide range of visceral and bodily reactions. Even Glover does not suggest that the behavioral response is expected in the general population. The expectation by Glover of this reaction is apparently only "when an opiate antagonist is initially administered to traumatized individuals diagnosed with PTSD" (Glover, 1995). Our point was that the subject in question, Mr. B, responded to opioid blockade in a manner very atypical for the general population. His history of trauma and diagnosis had been previously denied and was only discovered sub-